Invesco
GHDX

Invesco’s Genomic Health, Inc. GHDX Stock Holding History

Invesco’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-778,130
Closed -$52.8M – 3765
2019
Q3 		$52.8M Buy
778,130
+90,343
+13% +$6.2M 0.01% 971
2019
Q2 		$40M Buy
687,787
+522,627
+316% +$31M 0.01% 1118
2019
Q1 		$11.6M Sell
165,160
-22,761
-12% -$1.69M ﹤0.01% 1495
2018
Q4 		$12.1M Buy
187,921
+9,701
+5% +$680K ﹤0.01% 1432
2018
Q3 		$12.5M Sell
178,220
-7,454
-4% -$436K ﹤0.01% 1576
2018
Q2 		$9.36M Sell
185,674
-38,050
-17% -$1.51M ﹤0.01% 1717
2018
Q1 		$7M Buy
223,724
+16,239
+8% +$539K ﹤0.01% 1755
2017
Q4 		$7.1M Sell
207,485
-4,877
-2% -$156K ﹤0.01% 1778
2017
Q3 		$6.82M Buy
212,362
+9,213
+5% +$291K ﹤0.01% 1773
2017
Q2 		$6.61M Buy
+203,149
New +$6.43M ﹤0.01% 1783
2015
Q3 		– Sell
-4,534
Closed -$126K – 4126
2015
Q2 		$126K Buy
+4,534
New +$128K ﹤0.01% 3824

Invesco's GHDX Position: Q4 2019 in Review

Invesco sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 778,130 shares — an estimated $52.8M sold.

Invesco first reported a position in GHDX in Q2 2015 and held it in 11 quarters. The position peaked at $52.8M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Invesco reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Invesco sold 778,130 Genomic Health, Inc. shares in Q4 2019, an estimated $52.8M.
  • Invesco first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 11 quarters.
  • Invesco's Genomic Health, Inc. position peaked at $52.8M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Invesco's 13F filing for Q4 2019, filed 14 Feb 2020.